The New Normal: Considerations for Restarting Research

image iconDuration: 1 hour

Throughout the COVID-19 pandemic, we have continually heard what the “new normal” could mean for our work lives, social lives, schools, communities, and our medical system. But what does it mean for research? What are some of the challenges facing sites, institutions, sponsors and CROs? Research has continued through the crisis, but the environment has changed.

In this webinar, Michele Russell-Einhorn, Joan Versaggi, Wendy Tate, and Judith Carrithers of Advarra will discuss key areas to consider as we look to ramp up research. Topics include required communication with stakeholders both within and external to the research organization, considerations when prioritizing the research portfolio, and process recommendations to ensure compliance and participant and staff safety.

Learning Objectives

Following this free webinar, attendees will be able to:
  • Analyze policies, procedures, and workflows that need review (and potential modification) due to COVID-19
  • Understand how to structure a plan to ensure communication, compliant documentation, and reporting from the shutdown period into the next phase of research conduct
  • Identify specific concerns relating to ongoing and new IRB review of research
  • Provide tools and resources to evolve research workflows, ensuring success in the post-COVID-19 landscape

Presented By
Michele Russell-Einhorn_orange.png

Michele Russell-Einhorn

JD
Chief Compliance Officer and Institutional Official
Advarra

Wendy Tate_dark green.png

Wendy Tate

PhD, GStat
Director, Research Operations
Advarra

Joan Versaggi_purple.png

Joan Versaggi

MBA
VP, Consulting
Advarra

Judith Carrithers_blue.png

Judith Carrithers

JD, MPA
Director of Regulatory Affairs
Advarra



Register Now